A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma
Juno Therapeutics, a Subsidiary of Celgene
Juno Therapeutics, a Subsidiary of Celgene
Medical College of Wisconsin
Fate Therapeutics
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Janssen Scientific Affairs, LLC
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Cedars-Sinai Medical Center
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Celgene
Northside Hospital, Inc.
National Heart, Lung, and Blood Institute (NHLBI)
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
University of Rochester
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Baylor College of Medicine
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Massachusetts General Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Baylor College of Medicine
M.D. Anderson Cancer Center
University of Arkansas